Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 2, 2000, Pages 199-203

  Ono, Seiitsu ^a   Hu, Jianguo ^b   Imai, Takashi ^c   Shimizu, Natsue ^a   Tsumura, Mayumi ^b   Nakagawa, Hachiro ^b  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BML   (Japan)

^c National Chiba Higashi Hospital   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Immunohistochemistry; Insulin like growth factor I

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD VESSEL; CELL SURVIVAL; CONTROLLED STUDY; DERMIS; DISEASE COURSE; EPIDERMIS; FEMALE; HUMAN; MALE; METABOLISM; MOTONEURON; OPTICAL DENSITY; PRIORITY JOURNAL; SKIN;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD VESSELS; DERMIS; DISEASE PROGRESSION; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; SEBACEOUS GLANDS; SWEAT GLANDS;

EID: 0033925827     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.2.199     Document Type: Article

References (29)

1. Hirano A, Iwata M. Pathology of motor neurons with special reference to amyotrophic lateral sclerosis and related diseases. In: Tsubaki T, Toyokura Y, eds. Amyotrophic lateral sclerosis. Baltimore: University Park Press, 1979;107-33.
2. Doré S, Kar S, Quirion R. Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci 1997;20:326-31.
3. Lange DJ, Felice KJ, Festoff BW, et al. Reconbinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North America ALS/IGF-I Study Group. Neurology 1996;47(suppl 2): S93-5.
4. Carson MJ, Behringer RR, Brinster RL, et al. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993;10: 729-40.
5. Sjoberg J, Kanje M. Insulin-like growth factor (IGF-I) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res 1989;485:102-8.
6. Ang LC, Bhaumick B, Munoz DG, et al. Effects of astrocytes, insulin, and insulin-like growth factor I on the survival of motoneurons in vitro. J Neurol Sci 1992;109: 168-72.
7. Caroni P, Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J Cell Biol 1990;110:1307-17.
8. Roth GA, Spada V, Hamill K, et al. Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue. Brain Res Dev Brain Res 1995;88:102-8.
9. Lewis M, Vaught J, Neff TN, et al. The potential of insulin like growth factor-I as a therapeutic for the treatment of neuromuscular disorders. Ann NY Acad Sci 1993;692:201-8.
10. Appel SH. An unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism and Alzheimer disease. Ann Neurol 1981;10:499-505.
11. Martin JE. Neurotrophic factors and neurodegeneration. In: Leigh PN, Swash M, eds. Motor neuron disease. New York: Springer Verlag, 1995:241-58.
12. Hanta D, Akaaboune M, Lagord C, et al. Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease. J Neurol Sci 1995;129(suppl):122-6.
13. Lai EC, Felice KJ, Festoff BW, et al. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. Neurology 1997;49:1621-30.
14. Borasio GD, Robberecht W, Leigh PN, et al. A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. Neurology 1998;51:583-6.
15. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):96-107.
16. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Maryland State Medical Journal 1965;14: 61-5.
17. Hsu SM, Raine L, Fanger H. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29: 577-80.
18. Goldstein RH, Poliks CF, Pilch PF, et al. Stimulation of collagen formation by insulin and insulin-like growth factor I in culture of human lung fibroblasts. Endocrinology 1989;124:964-70.
19. Bhora FY, Dunkin BJ, Batzri S, et al. Effect of growth factors on cell proliferation and epithelialization in human skin. J Surg Res 1995;59:236-44.
20. Gartner MH, Benson JD, Caldwell MD. Insulin-like growth factors I and II expression in the healing wound. J Surg Res 1992;52:389-94.
21. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993;165:728-37.
22. Furukawa T, Toyokura Y. Amyotrophic lateral sclerosis and bedsores. Lancet 1976;i:862.
23. Reiser K. Effect of aging and diet restriction on collagen synthesis and crosslinking in a model of wound healing. Journal of Geriatric Dermatology 1993;1:87-96.
24. Spanheimer R, Zlatev T, Umpierrez G, et al. Collagen production in fasted and food-restricted rats: response to duration and severity of food deprivation. J Nutr 1991;121: 518-24.
25. Reiser KM. Influence of age and long-term dietary restriction on enzymatically mediated crosslinks and nonenzymatic glycation of collagen in mice. J Gerontol 1994;49:71B-9.
26. Ono S, Toyokura Y, Mannen T, et al. Amyotrophic lateral sclerosis: histological, histochemical, and ultrastructural abnormalities of skin. Neurology 1986;36:948-56.
27. Ono S, Mechanic GL, Yamauchi M. Amyotrophic lateral sclrosis: unusually low content of collagen. J Neurol Sci 1990;100:234-7.
28. Ono S, Yamauchi M. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis. Ann Neurol 1992;31:305-10.
29. Ono S, Yamauchi M. Amyotrophic lateral sclerosis: increased solubility of skin collagen. Neurology 1992;42: 1535-9.